Electronic Quality Management System (EQMS) For Pharma And Medtech Market Report 2026

Electronic Quality Management System (EQMS) For Pharma And Medtech Market Overview

• Electronic Quality Management System (EQMS) For Pharma And Medtech market size has reached to $2.9 billion in 2025 • Expected to grow to $5.22 billion in 2030 at a compound annual growth rate (CAGR) of 12.4% • Growth Driver: Increasing Regulatory Inspections And Audits Driving The Market Growth Due To Rising Compliance Requirements • Market Trend: Innovation In AI-Driven Quality And Compliance Automation For Life Sciences • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Electronic Quality Management System (EQMS) For Pharma And Medtech Market?

Electronic quality management system (EQMS) for pharma and medtech refers to digital platforms designed to manage and automate quality-related processes across regulated life sciences environments. These systems enable structured handling of quality events, including deviations, corrective and preventive actions (CAPA), document control, audits, compliance tracking, and training management. The main components of electronic quality management system (EQMS) for pharma and medtech include software and services. Software refers to digital platforms that streamline quality processes, ensure regulatory compliance, and manage documentation across pharmaceutical, biotechnology, and medical device organizations. These solutions are deployed through on premises and cloud based models and are adopted by small and medium enterprises and large enterprises. The key applications of document management, change management, corrective and preventive action management, training management, audit management, supplier quality management, and others, while the end-users includes pharmaceutical companies, biotechnology companies, medical device manufacturers, and others.

What Is The Electronic Quality Management System (EQMS) For Pharma And Medtech Market Growth Forecast?

The electronic quality management system (EQMS) for pharma and medtech market size is expected to see rapid growth in the next few years. It will grow to $5.22 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to growing adoption of cloud-based EQMS platforms across life sciences organizations, increasing investment in predictive quality and risk management capabilities, rising demand for integrated supplier quality management solutions, expanding implementation of automated compliance monitoring frameworks, increasing focus on scalable quality management systems for global operations. Major trends in the forecast period include increasing adoption of centralized quality event management platforms, growing implementation of automated CAPA workflows for compliance management, rising demand for digital document control and version management systems, expanding use of audit management solutions to strengthen regulatory readiness, increasing focus on employee training and qualification tracking across regulated environments.

Global Electronic Quality Management System (EQMS) For Pharma And Medtech Market Segmentation

1) By Component: Software; Services 2) By Deployment Mode: On Premises; Cloud Based 3) By Enterprise Size: Small And Medium Enterprises; Large Enterprises 4) By Application: Document Management; Change Management; Corrective And Preventive Action Management; Training Management; Audit Management; Supplier Quality Management; Other Applications 5) By End User: Pharmaceutical Companies; Biotechnology Companies; Medical Device Manufacturers; Other End Users Subsegments: 1) By Software: Document Control And Management Software; Corrective And Preventive Action Management Software; Audit Management Software; Training And Compliance Management Software; Risk Management And Analytics Software 2) By Services: Implementation And Integration Services; Validation And Compliance Services; Consulting And Advisory Services; Training And Support Services; Maintenance And Upgrade Services

What Is The Driver Of The Electronic Quality Management System (EQMS) For Pharma And Medtech Market?

The increasing regulatory inspections and audits is expected to propel the growth of the electronic quality management system (EQMS) for pharma and medtech market going forward. Regulatory inspections and audits refer to structured evaluations conducted by health authorities to verify that pharmaceutical and medical technology organizations comply with established quality and safety standards. Regulatory inspections and audits are rising due to increasingly stringent compliance requirements imposed by health authorities to ensure product quality, patient safety, and data integrity. Electronic quality management system (EQMS) for pharma and medtech supports regulatory inspections and audits by centralizing quality records, automating compliance processes, and ensuring quick access to accurate audit documentation. For instance, in March 2024, according to the twelfth annual survey of International Forum of Independent Audit Regulators (IFIAR), a Japan-based organization, all five inspection areas recorded an increase in the proportion of listed PIE audits inspected that identified at least one finding compared to the 2022 survey. Therefore, the increasing regulatory inspections and audits are driving the growth of the electronic quality management system (EQMS) for pharma and medtech industry.

Key Players In The Global Electronic Quality Management System (EQMS) For Pharma And Medtech Market

Major companies operating in the electronic quality management system (eqms) for pharma and medtech market are Oracle Corporation; Siemens AG; Honeywell International Inc.; IQVIA Holdings Inc.; Dassault Systèmes SE; Veeva Systems Inc.; MetricStream Inc.; MasterControl Inc.; ETQ (RPS Inc.); Ideagen plc; PSC Software; Ennov Group; ComplianceQuest Inc.; AmpleLogic Private Limited; AssurX Inc.; Intellect Design Arena Limited; Greenlight Guru LLC; Qualio Technologies Limited; Dot Compliance Ltd.; Scilife NV; QT9 Software Inc.; Omnex Systems LLC; Orcanos Ltd.; ZenQMS LLC; Trackmedium Pty Ltd.; Qualtrax; Pilgrim Quality Solutions

Global Electronic Quality Management System (EQMS) For Pharma And Medtech Market Trends and Insights

Major companies operating in the electronic quality management system (EQMS) for pharma and medtech market are focusing on developing innovative solutions, such as artificial intelligence (AI)-powered quality management platforms to enhance regulatory compliance, automate documentation workflows, and improve operational efficiency in life sciences organizations. Artificial Intelligence (AI)-powered quality management platforms are digital systems that use machine learning and automation to manage quality assurance and compliance processes, helping pharmaceutical and medtech companies reduce manual errors, streamline documentation, improve regulatory compliance, and accelerate decision-making. For instance, in April 2023, Dot Compliance, an Israel-based provider of compliance and quality management software for life sciences, launched the industry’s first AI-based ChatGPT-powered eQMS for life sciences. The platform integrates embedded generative and predictive artificial intelligence with proprietary algorithms to automate quality management tasks, optimize compliance workflows, and improve reporting accuracy. It enables quality assurance professionals to automate document creation, deviation management, and regulatory reporting while enhancing organizational compliance performance. The solution is designed as a ready-to-use cloud-based platform that supports pharmaceutical and medtech companies in accelerating product development timelines and adapting to evolving regulatory requirements.

What Are Latest Mergers And Acquisitions In The Electronic Quality Management System (EQMS) For Pharma And Medtech Market?

In April 2024, Clarivate Plc, a UK-based healthcare and information technology company, acquired Global QMS Inc. for an undisclosed amount. With this acquisition, Clarivate Plc aimed to strengthen its Life Sciences & Healthcare segment by integrating cloud-based regulatory reporting and compliance management solutions, thereby expanding its capabilities in manufacturing, supply chain management, and workflow automation for pharmaceutical, medtech, and biotech companies. Global QMS Inc. is a US-based healthcare technology company that specializes in providing quality-management-related solutions and consulting for regulated industries including pharmaceutical and medical device manufacturing.

Regional Outlook

North America was the largest region in the electronic quality management system (EQMS) for pharma and medtech market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Electronic Quality Management System (EQMS) For Pharma And Medtech Market?

The electronic quality management system (EQMS) for pharma and medtech market consists of revenues earned by entities by providing services such as software licensing and subscription, cloud-based deployment, system integration with enterprise and manufacturing systems, workflow automation, validation and compliance support, consulting, implementation services, training, technical support, and software maintenance and upgrades. The market value includes the value of related goods and digital tools sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end users are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Electronic Quality Management System (EQMS) For Pharma And Medtech Market Report 2026?

The electronic quality management system (eqms) for pharma and medtech market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the electronic quality management system (eqms) for pharma and medtech industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.